dose timing for igf-1 lr3 DOSES MASSIVE GROWTH! #askDave QK041 - Recombinant human/bovine/porcine IGF-1

The research findings have supported the cosmetic-ingredient use but do not constitute approval as a pharmaceutical hair-growth treatment in any major regulatory jurisdiction

Research indicates that CB2Rs may serve as potential therapeutic targets for these conditions, although further studies are needed to clarify their roles

However, susceptibility to proteolytic degradation and limited membrane permeability restrict their action to intracellular antioxidant pathways, thereby precluding the systemic immunomodulatory effects observed in other radioprotectants

Peptides need more FDA oversight, not less

doi:10.1007/s13671-021-00348-z 22Husain Z, Reddy BY, Schwartz RA